查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599694

微型RNA市场：按检测类型、产品类型、服务类型、应用划分 - 2025-2030 年全球预测

microRNA Market by Assay Type (Chemiluminescent Assays, Colorimetric Assays, Fluorescent Assays), Product (Consumables, Instruments), Services Type, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年微型RNA市值为21.2亿美元，预计2024年将达到27.2亿美元，复合年增长率为28.84%，到2030年将达到125.1亿美元。

微型RNA（miRNA）是一类非编码小RNA分子，在基因表现调控中发挥重要作用，在发育、分化、凋亡、代谢等多种生物过程中发挥重要作用。 miRNA研究的需求主要源自于其在疾病诊断、治疗和个人化医疗方面的潜在应用，例如肿瘤学、心血管疾病和神经退化性疾病。 miRNA 的最终用途包括製药公司、学术研究机构和诊断中心。影响 miRNA 市场的关键成长要素包括下一代定序技术的进步、慢性病盛行率的增加以及基因组学研究资金的增加。最新的机会在于人工智慧和 miRNA 的整合，以增强生物标记的发现和基于 miRNA 的疗法的开发，特别是针对遗传性疾病和癌症。为了利用这些机会，企业应该投资奈米技术等创新输送系统的研发，并与学术机构合作加速探索阶段。

主要市场统计
基准年[2023] 21.2亿美元
预测年份 [2024] 27.2亿美元
预测年份 [2030] 125.1亿美元
复合年增长率（%） 28.84%

然而，市场面临一些限制，例如 miRNA 生物合成的复杂性、治疗传递的挑战和严格的法律规范。样品处理和资料变异等技术问题也构成了重大挑战。我们可以透过开发用于全面 miRNA 分析的强大多重技术、改进资料分析计算工具以及提高预测模型的准确性来推动创新。相关人员之间的合作研究可以进一步扩大研究成果并缩短新开发产品的上市时间。 miRNA 领域是动态且不断发展的，需要灵活的策略以及对监管变化和技术进步的适应性。持续监控监管环境并培养公私伙伴关係关係有助于克服成长挑战。为了保持竞争力，公司应专注于建立个人化医疗解决方案并扩大非侵入性诊断的检测开发。部署转化研究来填补临床空白对于实现长期市场潜力和以患者为中心的结果也至关重要。

市场动态：揭示快速发展的微型RNA市场的关键市场洞察

供需的动态交互作用正在改变微型RNA市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病盛行率上升，癌症患者数量增加
    • 微型RNA在多种疾病诊断中的重要性日益增加
    • 探索微型RNA潜力的全球研究活动不断增加
  • 市场限制因素
    • 与微型RNA套件和其他产品相关的高成本
  • 市场机会
    • 用于疾病相关分析应用的微型RNA工具的出现
    • 基因组研究的进展以及支持研究活动的新工具的采用
  • 市场问题
    • 微型RNA安全性和毒性问题

波特五力：驾驭微型RNA市场的策略工具

波特的五力架构是了解微型RNA市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解微型RNA市场的外部影响

外部宏观环境因素在塑造微型RNA市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解微型RNA市场的竞争格局

对微型RNA市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵： 微型RNA市场供应商绩效评估

FPNV定位矩阵是评估微型RNA市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製微型RNA市场的成功之路

微型RNA市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：全面分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病发生率和癌症病例数增加
      • 微型RNA在各种疾病诊断中的重要性日益增加
      • 扩大研究活动，在全球探索微型RNA的潜力
    • 抑制因素
      • 与微型RNA套件和其他产品相关的高成本
    • 机会
      • 用于疾病相关分析应用的新型微型RNA工具
      • 基因组研究的进展和支持研究工作的新工具的引入
    • 任务
      • 微型RNA安全性和毒性问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章微型RNA市场：依检测类型

  • 介绍
  • 化学冷光分析
  • 比色测定
  • 萤光测定
  • 免疫检测
  • miRNA阵列
  • 次世代定序
  • 基于 PCR 的检测

第 7 章微型RNA市场：副产品

  • 介绍
  • 消耗品
  • 装置

第 8 章微型RNA市场：依服务型

  • 介绍
  • 功能研究服务
  • 微阵列服务

第 9 章微型RNA市场：依应用分类

  • 介绍
  • 癌症
  • 心血管疾病
  • 免疫疾病
  • 感染疾病
  • 神经系统疾病

第10章 美洲微型RNA市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太微型RNA市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的微型RNA市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abcam PLC
  • Bio-Rad Laboratories, Inc.
  • Global Life Sciences Solutions USA LLC
  • HTG Molecular Diagnostics, Inc.
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc
  • Lexogen GmbH
  • Meridian Bioscience Inc
  • New England Biolabs (UK) Ltd.
  • Norgen BIoTek Corp.
  • Oxford Nanopore Technologies Limited
  • Rosetta Genomics Ltd.
  • Sigma Aldrich Corp.
  • System Biosciences, LLC
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies, Inc.
Product Code: MRR-02026C4C98C4

The microRNA Market was valued at USD 2.12 billion in 2023, expected to reach USD 2.72 billion in 2024, and is projected to grow at a CAGR of 28.84%, to USD 12.51 billion by 2030.

MicroRNAs (miRNAs) are small non-coding RNA molecules playing a crucial role in regulating gene expression, making them significant in various biological processes such as development, differentiation, apoptosis, and metabolism. The necessity of miRNA research stems from its potential applications in disease diagnostics, therapeutics, and personalized medicine, predominantly in oncology, cardiovascular diseases, and neurodegenerative disorders. The end-use of miRNAs encompasses pharmaceutical companies, academic and research institutions, and diagnostic centers. Key growth factors influencing the miRNA market include advancements in next-generation sequencing technologies, growing prevalence of chronic diseases, and increased funding in genomics research. The latest opportunities lie in the integration of miRNA with artificial intelligence for enhanced biomarker discovery and in developing miRNA-based therapeutics, specifically targeting genetic disorders and cancers. To leverage these opportunities, companies should invest in R&D for innovative delivery systems like nanotechnology and collaborate with academic institutions to accelerate discovery phases.

KEY MARKET STATISTICS
Base Year [2023] USD 2.12 billion
Estimated Year [2024] USD 2.72 billion
Forecast Year [2030] USD 12.51 billion
CAGR (%) 28.84%

However, the market faces limitations such as the complexity of miRNA biogenesis, delivery challenges in therapeutics, and stringent regulatory frameworks. Technical issues in sample handling and data variability also pose significant challenges. Forging ahead, innovation can be driven by developing robust multiplexing technologies for comprehensive miRNA profiling and improving computational tools for data analysis to enhance predictive modeling accuracy. Collaborations among stakeholders can further amplify research outputs and reduce time-to-market for new developments. The miRNA sector is dynamic and fast-evolving, demanding agile strategies and adaptability to regulatory changes and technological advances. Continuous monitoring of regulatory landscapes and fostering public-private partnerships can aid in overcoming growth challenges. Businesses should focus on building personalized medicine solutions and expanding the assay development for non-invasive diagnostics to stay competitive. Deploying translational research to bridge clinical gaps can also serve as a pivotal point for achieving long-term market potential and patient-centric outcomes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving microRNA Market

The microRNA Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of chronic diseases and rising number of cancer cases
    • Growing importance of microRNA for the diagnosis of several diseases
    • Increasing research activities exploring the potential of microRNA globally
  • Market Restraints
    • High cost associated with microRNA kits and other products
  • Market Opportunities
    • Emerging microRNA tools for disease-associated analytical applications
    • Advancement in genomic studies and adoption of new tools for supporting research endeavors
  • Market Challenges
    • Safety and toxicity issues of microRNA

Porter's Five Forces: A Strategic Tool for Navigating the microRNA Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the microRNA Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the microRNA Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the microRNA Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the microRNA Market

A detailed market share analysis in the microRNA Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the microRNA Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the microRNA Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the microRNA Market

A strategic analysis of the microRNA Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the microRNA Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Bio-Rad Laboratories, Inc., Global Life Sciences Solutions USA LLC, HTG Molecular Diagnostics, Inc., Illumina, Inc., Integrated DNA Technologies, Inc, Lexogen GmbH, Meridian Bioscience Inc, New England Biolabs (UK) Ltd., Norgen Biotek Corp., Oxford Nanopore Technologies Limited, Rosetta Genomics Ltd., Sigma Aldrich Corp., System Biosciences, LLC, Thermo Fisher Scientific Inc., and TriLink BioTechnologies, Inc..

Market Segmentation & Coverage

This research report categorizes the microRNA Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Assay Type, market is studied across Chemiluminescent Assays, Colorimetric Assays, Fluorescent Assays, Immunoassay, miRNA Arrays, Next-Generation Sequencing, and PCR-Based Assay.
  • Based on Product, market is studied across Consumables and Instruments.
  • Based on Services Type, market is studied across Functional Studies Services and Microarray Services.
  • Based on Application, market is studied across Cancer, Cardiovascular Disease, Immunological Disorder, Infectious Diseases, and Neurological Diseases.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of chronic diseases and rising number of cancer cases
      • 5.1.1.2. Growing importance of microRNA for the diagnosis of several diseases
      • 5.1.1.3. Increasing research activities exploring the potential of microRNA globally
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with microRNA kits and other products
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging microRNA tools for disease-associated analytical applications
      • 5.1.3.2. Advancement in genomic studies and adoption of new tools for supporting research endeavors
    • 5.1.4. Challenges
      • 5.1.4.1. Safety and toxicity issues of microRNA
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. microRNA Market, by Assay Type

  • 6.1. Introduction
  • 6.2. Chemiluminescent Assays
  • 6.3. Colorimetric Assays
  • 6.4. Fluorescent Assays
  • 6.5. Immunoassay
  • 6.6. miRNA Arrays
  • 6.7. Next-Generation Sequencing
  • 6.8. PCR-Based Assay

7. microRNA Market, by Product

  • 7.1. Introduction
  • 7.2. Consumables
  • 7.3. Instruments

8. microRNA Market, by Services Type

  • 8.1. Introduction
  • 8.2. Functional Studies Services
  • 8.3. Microarray Services

9. microRNA Market, by Application

  • 9.1. Introduction
  • 9.2. Cancer
  • 9.3. Cardiovascular Disease
  • 9.4. Immunological Disorder
  • 9.5. Infectious Diseases
  • 9.6. Neurological Diseases

10. Americas microRNA Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific microRNA Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa microRNA Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC
  • 2. Bio-Rad Laboratories, Inc.
  • 3. Global Life Sciences Solutions USA LLC
  • 4. HTG Molecular Diagnostics, Inc.
  • 5. Illumina, Inc.
  • 6. Integrated DNA Technologies, Inc
  • 7. Lexogen GmbH
  • 8. Meridian Bioscience Inc
  • 9. New England Biolabs (UK) Ltd.
  • 10. Norgen Biotek Corp.
  • 11. Oxford Nanopore Technologies Limited
  • 12. Rosetta Genomics Ltd.
  • 13. Sigma Aldrich Corp.
  • 14. System Biosciences, LLC
  • 15. Thermo Fisher Scientific Inc.
  • 16. TriLink BioTechnologies, Inc.

LIST OF FIGURES

  • FIGURE 1. MICRORNA MARKET RESEARCH PROCESS
  • FIGURE 2. MICRORNA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MICRORNA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MICRORNA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MICRORNA MARKET SIZE, BY ASSAY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MICRORNA MARKET SIZE, BY ASSAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MICRORNA MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MICRORNA MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MICRORNA MARKET SIZE, BY SERVICES TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MICRORNA MARKET SIZE, BY SERVICES TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MICRORNA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MICRORNA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MICRORNA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MICRORNA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MICRORNA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MICRORNA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MICRORNA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MICRORNA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MICRORNA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MICRORNA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MICRORNA MARKET DYNAMICS
  • TABLE 7. GLOBAL MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MICRORNA MARKET SIZE, BY CHEMILUMINESCENT ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MICRORNA MARKET SIZE, BY COLORIMETRIC ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MICRORNA MARKET SIZE, BY FLUORESCENT ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MICRORNA MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MICRORNA MARKET SIZE, BY MIRNA ARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MICRORNA MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MICRORNA MARKET SIZE, BY PCR-BASED ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MICRORNA MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MICRORNA MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MICRORNA MARKET SIZE, BY FUNCTIONAL STUDIES SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MICRORNA MARKET SIZE, BY MICROARRAY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MICRORNA MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MICRORNA MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MICRORNA MARKET SIZE, BY IMMUNOLOGICAL DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MICRORNA MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MICRORNA MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS MICRORNA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES MICRORNA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC MICRORNA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. MICRORNA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. MICRORNA MARKET, FPNV POSITIONING MATRIX, 2023